56-cessation-database

$99,999,999.00

In stock

SKU

2087

Asset valuation: $15,000,000,000. AI-Generated Cessation Research Substrate for Pharma R&D Acquisition (Product title updated from earlier working name "Universal Non-Chemical Cessation Alchemy Database". Canonical title is now "Cessation Alchemy Data".)

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Details

Valuation

Generous asset valuation: $15,000,000,000. The listed price is the platform maximum; acquisition at valuation is handled by direct enquiry.

Project 56 — Cessation Alchemy Data — the Alchemical Architecture for Cessation (UCF family, 6 forces × 9 protocols)

AI-Generated Cessation Research Substrate for Pharma R&D Acquisition

(Product title updated from earlier working name "Universal Non-Chemical Cessation Alchemy Database". Canonical title is now "Cessation Alchemy Data".)

> Time is a prayer. Cessation is time work. Every receptor system heals on a measurable timeline. Every day of abstinence is a physical prayer to the future self you are becoming.

Author: Christopher Gabriel Brown

Date: 2026-07-03

Version: 3.1.0

Classification: NON-OPIOID · NON-CHEMICAL PRIMARY · PATENT-PENDING

Commercial status: STANDALONE SALE — not included in the All-In-One bundle

Database size: 134 KB structured JSON

Disclaimer

Computational research findings — not medical advice, not clinically tested, not FDA-approved. Deliverables are R&D substrate for pharma-industry validation and clinical program design.

What This Is

A first-of-its-kind AI-generated cessation research substrate. Six Universal Cessation Forces (UCFs) applied across nine substance and dual-diagnosis categories, cross-referenced against ten companion research projects. Doctor-grade clinical modules include an objective withdrawal test, six-panel blood work module, drug detection windows for 19 substances, 14-nutrient toxicology with drug-nutrient interactions, precision dosing, non-chemical pain management, and an individualized resolution computation engine.

The Six Universal Cessation Forces

Substance Coverage (9 categories)

Nicotine / Tobacco
Alcohol (medical warning)
Opioids (non-opioid protocol)
Cannabis / Marijuana
Stimulants (cocaine, meth, amphetamines)
LSD / Psilocybin / DMT / Mescaline
HPPD (Hallucinogen Persisting Perception Disorder) — dedicated protocol
Substance-Induced Psychotic Disorder (dual-diagnosis)
Universal Daily Protocol (any substance)

Doctor-Grade Clinical Modules

1. UCF Withdrawal Index (UWI) — The Missing Test

The test Chris wished he had. 10 domains (physical, sleep, autonomic, appetite, mood, cognitive, cravings, anhedonia, social, substance-thought autonomy), each scored 0-4. Total 0-40. Answers the hardest question in recovery: "am I healed yet?"

30-40: Acute withdrawal
20-29: Post-acute withdrawal, severe
10-19: Post-acute withdrawal, moderate — improving
5-9: Late recovery — almost out
0-4: CLEARED — you are out of withdrawal

2. Cessation Completion Certificate

Objective criteria for the recovery discharge summary that addiction medicine has lacked. UWI ≤4 for 30 days + negative urine + negative hair (90 days) + normal blood work + minimum abstinence time = signed completion milestone.

3. Blood Test + Lab Panel Module (6 panels)

1. Baseline intake — CBC, CMP, LFTs, TSH, lipids, HbA1c, UA, pregnancy

2. Nutrient status — Vit D, iron studies, B12/MMA, folate/homocysteine, Mg, Zn, Cu/ceruloplasmin, Se, omega-3 index

3. Neurotransmitter metabolites — 5-HIAA, HVA, VMA, MHPG, cortisol curve, serum BDNF

4. Substance-specific — GGT/CDT/MCV for alcohol, hep/HIV/testosterone for opioid, ECG/troponin/echo for stimulant, cognitive testing for cannabis, EEG/MRI for HPPD

5. Inflammation + recovery — hsCRP, IL-6, TNF-alpha, homocysteine

6. Clearance certification — the labs required to sign the Completion Certificate

4. Drug Testing Reference Module

Detection windows for 19 substances across urine, blood, saliva, hair, EtG, breath. Includes 10-item false-positive avoidance list (poppy seeds → opiate positive; hemp seeds → THC positive; pseudoephedrine/bupropion/trazodone → amphetamine positive; kombucha → EtG positive).

5. Toxicology Module

14 nutrients with RDA, UL, therapeutic range, toxic threshold, overdose symptoms, contraindications, form bioavailability, drug interactions, rescue protocols. 10-row drug-nutrient interaction matrix (SSRIs vs tryptophan/5-HTP → serotonin syndrome; MAOIs vs tyrosine → hypertensive crisis; warfarin vs omega-3; levothyroxine vs iron/calcium/magnesium/zinc).

6. Precision Dosing Module

9 interventions with exact acute-withdrawal doses, maintenance doses, blood-level targets, form selection, timing, onset, duration. Includes renal/hepatic dose adjustments.

7. Pain During Cessation Module

Cessation is a state of high pain. 7 substance-specific pain profiles with VAS severity, mechanism, clinical scale references (CIWA-Ar for alcohol, COWS for opioid, CWS for cannabis). 19 non-chemical pain interventions across physical, psychic, and sleep pain — each with mechanism, dose, cost, evidence citation.

8. Resolution Computation Engine

The product computes a resolution. Input: substance + days abstinent + UWI score + medications + labs + demographics. Output: individualized UCF stack for this week, precision doses, pain interventions, drug-test schedule, blood-panel schedule, expected receptor-recovery timeline, medical escalation criteria, next review date.

Chemistry Comparison Chart

8 FDA-approved cessation compounds benchmarked: Varenicline (Chantix), Bupropion (Zyban), Cytisine (Tabex), Naltrexone (Vivitrol), Acamprosate (Campral), Disulfiram (Antabuse), Lofexidine (Lucemyra), NAC. Molecular formula, class, target, design-target efficacy, side-effect profile, cost range, and UCF overlap analysis for each.

History + Predictions + Counsel

25-event historical timeline — 1935 AA founding through 2026 Project 56
7 five-year predictions — GLP-1 as cessation adjunct, psilocybin FDA breakthrough, DTx 3-5x market growth, nutritional psychiatry mainstream, HPPD guidance, substance-induced psychosis DSM sub-category, precision cessation programs
3 ten-year predictions — AI-generated recovery plans standard-of-care, non-chemical parity with chemical programs, "cessation graduation" displaces "lifelong recovery"
Strategic counsel for pharma R&D, digital therapeutics builders, CROs, clinicians
5 documented failure modes to avoid

Companion Research Projects (Separately Available)

Commercial Tiers

IP retained by CGB across all tiers. No IP or patent license conveyed.

Acquisition Terms

USA-only buyers. USD only.
Email + postal only. No phone. No brokers.
Georgia governing law. All sales final.
NOT included in the All-In-One bundle — this is a standalone acquisition.

Store Integration

Product cards for the three destination store pages are in store_integration/:

research_card.html → https://cri-one.com/store/research.html
health_wellness_card.html → https://cri-one.com/store/browse-by-sector/health-wellness.html
all_products_card.html → https://cri-one.com/store/all-products.html
product_summary_block.html — reusable summary block
STORE_INTEGRATION_NOTES.md — push instructions

Files

cessation_pharma_database.json — 134 KB structured JSON (v3.1.0)
cessation_query.py — interactive query tool + resolution computation engine
README.md — this file
BUYER_PITCH.md — pharma acquisition pitch
LICENSING.md — tier ladder and terms
HANDOFF_BLURB.md — short deliverable handoff
MANIFEST.json — package manifest
WEB_DESCRIPTION.html — store-ready HTML description
store_integration/ — store page cards
07-alchemy-probability-data/ — reference substrate
1 light trigger.txt — inventor IP catalog

Usage

python cessation_query.py               # interactive shell
python cessation_query.py report        # full printed report
python cessation_query.py uwi           # the Withdrawal Index test
python cessation_query.py blood         # blood test + lab panels
python cessation_query.py drugtest      # drug detection windows
python cessation_query.py pain opioid   # pain profile + management
python cessation_query.py tox magnesium # nutrient toxicology
python cessation_query.py dose thiamine # precision dosing

Interactive commands include: anchor, forces, protocol <s>, uwi, blood, drugtest [s], compute <s> <days> <uwi>, pain [s], tox [n], dose [n], interactions, chem, history, predictions, counsel, tiers, full, quit.

Example: computing a resolution

python cessation_query.py
cessation> compute opioids 45 22

Outputs the individualized weekly UCF stack, precision doses, drug-test schedule, days remaining to Completion Certificate eligibility, and receptor recovery timeline for a patient 45 days into opioid cessation with UWI of 22 (post-acute severe).

Contact

Christopher Gabriel Brown

1341 Wellington Cove, Lawrenceville, GA 30043-5255, USA

Email: crioneaka@outlook.com | crioneaka@outlook.com

Store: cri-one.com/store

Email + postal only. USA-only. USD only.

Buyer Pitch — Project 56

Cessation Alchemy Data — the Alchemical Architecture for Cessation

(UCF family, 6 forces × 9 protocols)

For pharma-industry acquisition. Standalone. Not bundled.

Disclaimer

Computational research findings — not medical advice, not clinically tested, not FDA-approved. Deliverables are R&D substrate for pharma-industry validation and clinical program design.

The 30-Second Version

A pharma acquirer buys a first-of-its-kind AI-generated cessation research substrate. Five Universal Cessation Forces (UCFs) × five substance protocols (nicotine, alcohol, opioids, cannabis, stimulants) × ten companion research projects = a differentiated non-chemical cessation program that opens IP space adjacent to existing cessation pharmacotherapy — without competing on molecule design.

Why This Matters Now

The addiction crisis is a category emergency.

The U.S. opioid crisis kills 80,000+ Americans per year (design-target figure from published mortality categories).
Global addiction economic burden exceeds $600B per year in the U.S. alone (aggregate across healthcare, productivity, criminal justice).
Existing cessation pharmacotherapy relies on a handful of aging molecules — varenicline, bupropion, cytisine, naltrexone, acamprosate, disulfiram, lofexidine — each with modest efficacy and meaningful side-effect profiles.
Pipeline is thin. Big pharma has largely exited addiction molecule design.

Where the opportunity is.

Non-chemical cessation is a rapidly-legitimizing category: digital therapeutics, nutritional neuroscience, exercise medicine, sleep medicine, gut-microbiome interventions.
Each of these categories has isolated evidence bases. No one has assembled them into a unified substrate.
Project 56 is that assembly.

What the Substrate Contains

1. The Five UCF Framework

An original scientific organizing principle that lets a pharma R&D team categorize non-chemical cessation interventions, design clinical trials around them, and build brand differentiation.

UCF-1 Precursor Restoration — endogenous neurotransmitter synthesis pathway data mapped per substance
UCF-2 Reward Reactivation — 28 non-chemical reward-generating activities, each with mechanism + evidence citation
UCF-3 Neuroplasticity Rewiring — BDNF enhancement, habit-loop replacement, sleep architecture
UCF-4 Elemental Repair — 20 brain-critical elements mapped to substance-specific depletion
UCF-5 Gut-Brain Restoration — 4-phase microbiome protocol

2. Five Substance Protocols

Complete 5-UCF protocols for nicotine, alcohol, opioids, cannabis, stimulants — each protocol integrates precursors, reward activities, neuroplasticity accelerators, elemental cofactors, and gut restoration.

3. Evidence Substrate

25+ citations to published peer-reviewed research on the neurobiology underlying each UCF and each substance protocol.

4. Companion Cross-References

The substrate is scaffolded against ten companion research projects from the inventor's portfolio — brain chemistry, disease cure research, alchemy probability, health recovery. Each companion is separately available.

5. Receptor Recovery Timeline Data

Documented recovery timelines for the receptor systems damaged by each substance — supporting the design-target claim that the brain heals on a measurable timeline.

6. Query Tooling

cessation_query.py — interactive Python tool for querying the substrate by force, substance, element, reward pathway, or free-text search.

Why a Pharma Acquirer Buys This

Category positioning. Adding a differentiated non-chemical cessation arm to an existing cessation program creates a defensible category the acquirer can own. Competitors are focused on molecule design; this substrate is the framework layer.

Clinical program design. The 5-UCF framework gives clinical operations teams a ready-made schema for designing addiction recovery trials that isolate non-chemical variables (precursors, reward activities, elements, gut interventions).

Differentiation. Non-opioid positioning is regulatory-favored. Non-chemical positioning is brand-favored. Both open marketing latitude that pharma competitors do not have.

Integration paths. The substrate integrates cleanly with digital therapeutics (each UCF is app-deliverable), consumer-health supplement lines (UCF-4 is a supplement roadmap), and existing molecule programs (UCFs are additive to pharmacotherapy).

No molecule risk. The acquirer does not inherit a compound with clinical-trial risk. The substrate is a research substrate — the acquirer chooses the validation path.

Commercial Tiers

IP retained by CGB across all tiers. Sale conveys research/design deliverables and commercialization rights per tier — never patent licenses.

Candidate Acquirer Categories

Big-pharma cessation & CNS R&D divisions
Digital therapeutics companies with cessation programs
Contract research organizations specializing in addiction/CNS trials
Consumer-health companies with nutritional-neuroscience programs
Government / foundation research funders (NIH/NIDA-adjacent)
Academic medical centers with addiction research programs

Terms Summary

IP retained by inventor across all tiers
USA-only buyers; USD only
Email + postal contact only; no phone; no brokers
Governing law: Georgia, Gwinnett County
All sales final and non-refundable
Standalone acquisition (not part of the All-In-One bundle)

Contact

Christopher Gabriel Brown

1341 Wellington Cove, Lawrenceville, GA 30043-5255, USA

Email: crioneaka@outlook.com | crioneaka@outlook.com

Licensing — Project 56

Cessation Alchemy Data — the Alchemical Architecture for Cessation

(UCF family, 6 forces × 9 protocols)

Standalone acquisition. Patent-pending. IP retained by CGB.

Disclaimer

Computational research findings — not medical advice, not clinically tested, not FDA-approved. Deliverables are R&D substrate for pharma-industry validation and clinical program design.

IP Stance

Christopher Gabriel Brown retains all intellectual property, patent-pending status, and inventor rights across every tier of this offering. No tier conveys a patent license, IP license, exclusive rights, or ownership transfer.

Every tier conveys deliverables and commercialization rights within tier scope, not the underlying IP.

Tier Ladder

CEASE-56-RESEARCH — Licensed Research

Price: USD $9,997

What "Licensed" means: a document license to read, study, cite, and internally reference. Not a patent license.

Includes:

Full cessation_pharma_database.json (v3.0.0)
README, BUYER_PITCH, LICENSING, HANDOFF_BLURB, WEB_DESCRIPTION, MANIFEST
cessation_query.py interactive query tool (read-only license)
Evidence citation index

Excludes:

Commercialization rights
Right to build derivative research products
Consultation with inventor

Buyer profile: Academic research team, internal R&D screening, single-investigator use.

CEASE-56-DESIGN — Design Target

Price: USD $499,997

Everything in Licensed Research, plus:

Worldwide commercialization rights for research findings within acquirer's cessation program
Right to build and publish derived research works
Right to license findings into acquirer's internal cessation program
60-day email consultation window with inventor

Excludes:

Patent license or IP ownership
Right to resell the substrate as a standalone product
Extended consultation

Buyer profile: Pharma R&D division adding a non-chemical arm to an existing cessation program.

CEASE-56-COMPLETE — Complete

Price: USD $50,000,000

Everything in Design Target, plus:

12-month email + postal consultation with inventor
Cross-reference index to the ten companion research projects (07, 10, 11, 12, 13, 16, 22, 33, 41, 46)
Integration guidance for clinical program design
Pharma-industry outreach & positioning package
USA-based deliverable

Excludes:

Patent license or IP ownership
Companion project acquisitions (separately available)
Clinical trial services (buyer runs their own trials)

Buyer profile: Pharma / digital-therapeutics acquirer building a differentiated cessation program.

What You Do NOT Get at Any Tier

Patent license
IP license
Exclusive rights
Royalty-free use of any patent
Ownership transfer
Right to file continuation patents on inventor's work
Right to represent yourself as the inventor

Patent numbers are cited in the substrate as provenance (proving authorship and priority date), not as things being sold or licensed.

Companion Projects (Separately Available)

The Complete tier includes a cross-reference index to the following. Each companion is a separate acquisition and must be licensed separately.

Project 07 — Alchemy Probability Data
Project 10 — Diabetes Cure Discovery
Project 11 — Alzheimer's Cure Discovery
Project 12 — Parkinson's Cure Discovery
Project 13 — Disease Cure Research
Project 16 — Chemical Cooker
Project 22 — Brain Chemistry (NeuroElement)
Project 33 — Health Recovery
Project 41 — Alchemy Data Three
Project 46 — FDA to Store

Bundle Status

Project 56 is a standalone acquisition. It is NOT included in the All-In-One bundle. A buyer of the All-In-One does not receive Project 56.

Purchase Terms

Buyers: USA-only. Up to 4 USA-domiciled entities per transaction (joint & several liability).
Currency: USD only.
Contact channels: Email and postal only. No phone. No brokers or intermediaries.
Governing law: State of Georgia, Gwinnett County.
Finality: All sales final and non-refundable.
Delivery: USA-based. AES-256 encrypted package.

Contact

Christopher Gabriel Brown

1341 Wellington Cove, Lawrenceville, GA 30043-5255, USA

Email: crioneaka@outlook.com | crioneaka@outlook.com

Upload Checklist — Cessation Alchemy Data (Project 56)

Store: https://cri-one.com/store

Product URL target: https://cri-one.com/store/56-cessation-database.html

Version: 3.1.0 · Date: 2026-07-03

Bundle status: Standalone — NOT part of the All-In-One

Step 1 — Upload the images (Magento Media)

All PNGs live in figures/. Images are colorful, simple, and carry embedded description + date + copyright so they stand alone even without HTML context.

Upload to /store/media/project-56/ (or the equivalent Magento media directory):

Regenerate any time: python figures/generate_pngs.py

Step 2 — Create the Magento product

Product name:

Cessation Alchemy Data -- the Alchemical Architecture for Cessation (UCF family, 6 forces x 9 protocols)

Short description (paste into Magento short_description):

AI-generated cessation research substrate. 6 Universal Cessation Forces × 9 substance & dual-diagnosis protocols. Doctor-grade Withdrawal Test, 6-panel blood work, 19-substance drug detection, 14-nutrient toxicology, precision dosing, non-chemical pain management, Resolution Computation Engine, 8-compound chemistry comparison, 25-event history + 10 predictions, strategic counsel. Chemical Cooker (Project 16) recipe bridge included. Non-opioid · patent-pending · IP retained · standalone acquisition (not in the All-In-One).

Full description (paste cessation_store_description.html into Magento description field — full aerophi-pattern HTML with grey/black/white palette and embedded hero image).

Pricing (configurable, one tier per option):

Licensed Research — $9,997
Design Target — $499,997
Complete — $50,000,000

Category assignment:

Health & Wellness
Research
(also appears in All Products by default)

Attributes:

SKU: CEASE-56 (or your convention)
Patent status: Patent-pending
IP stance: Retained
Bundle status: Standalone

Step 3 — Insert store card snippets into destination pages

Paste each snippet into the corresponding Magento CMS page (using the Page Builder HTML widget):

Note: the snippets reference /store/media/project-56/cessation_*.png — deploy Step 1 first so the images resolve.

Step 4 — Publish and verify

1. Save the product in Magento admin

2. Reindex and flush cache (production mode is on per [[store-production-mode]])

3. Verify live at https://cri-one.com/store/56-cessation-database.html

4. Verify card appears on all three destination pages

5. Check thumbnail on /store/all-products.html?p=5 (where new products land)

6. Screenshot for records

Guardrails applied throughout

Says "patent-pending" not "patented"
"Computational research findings — not medical advice, not clinically tested, not FDA-approved"
Email + postal only; no phone; USA-only; USD only
IP retained; no patent license conveyed at any tier
No fabricated customer names or adoption claims

Files reference

Contact

Christopher Gabriel Brown · 1341 Wellington Cove, Lawrenceville, GA 30043-5255, USA

Email: crioneaka@outlook.com · crioneaka@outlook.com

Project 56 → Project 16 Chemical Cooker Compatibility

Cessation Alchemy Data → Chemical Cooker Recipe Bridge

Disclaimer

Computational research findings — not medical advice, not clinically tested, not FDA-approved. UCF-4 elemental repair reagents; buyer supplies validated mineral solutions.

What This Is

A bridge that converts Project 56's UCF-4 Elemental Repair formulations into Chemical Cooker recipe JSON + G-code. Enables a Chemical Cooker owner to physically cook the cessation UCF-4 mineral/element blends per substance.

What Gets Emitted

For each cessation substance target, two files:

cessation_<substance>_ucf4.json — Chemical Cooker recipe JSON (matches Cooker's published schema)
cessation_<substance>_ucf4.gcode — Ready-to-run G-code

Plus a MANIFEST.json describing all generated recipes.

Substances Covered

NICOTINE (C-H-N-O-S + Zn-Fe-Cu) — acetylcholine + dopamine restoration
ALCOHOL (C-H-N-O + Mg-Zn-Fe) — GABA + serotonin + dopamine; B1 handled as reagent priority
OPIOID (C-H-N-O + Fe-Cu-Zn-Mg) — endorphin + enkephalin + dopamine
CANNABIS (C-H-N-O-P + Mg-Zn) — anandamide + 2-AG + dopamine
STIMULANT (C-H-N-O + Fe-Cu-Zn-Se) — dopamine + serotonin + norepinephrine
PSYCHOSIS-DUAL (C-H-N-O-S + Mg-Zn) — anti-inflammatory + glutamate modulation
UNIVERSAL (C-H-N-O + Mg-Zn-Fe) — broad baseline UCF-4 support

Recipe Schema Followed

Matches 16-chemical-cooker/platform/lite_alchemy/schema.json:

{
  "source": "56-cesation-database",
  "compound_name": "CESSATION-<CODE>-<ELEMENTS>",
  "target_substance_cessation": "<substance>",
  "ucf_layer": "UCF-4 Elemental Repair",
  "target_neurotransmitter": "...",
  "priority_notes": "...",
  "formulation": {
    "elements": [ ... ],
    "volumes_ul": [ ... ],
    "vessels": [ "reservoir_1", ..., "well_1" ],
    "heat_celsius": <40-50>,
    "heat_time_sec": 300-360,
    "stir": true
  },
  "disclaimer": "...",
  "steps": [ move / dispense / heat / stir / wait ... ],
  "cooker_metadata": { ... }
}

Usage

Generate all recipes:

python cessation_ucf_to_recipe.py

Print a single recipe JSON:

python cessation_ucf_to_recipe.py opioid

Print G-code for a substance:

python cessation_ucf_to_recipe.py gcode stimulant

List available substances:

python cessation_ucf_to_recipe.py list

Cooker Owner Workflow

1. Purchase Project 56 at any tier ($9,997 / $499,997 / $50M).

2. Own or purchase Chemical Cooker (Project 16 — separate acquisition).

3. Load Project 56 recipe JSON into Chemical Cooker platform (platform/recipe_builder.py).

4. Supply validated mineral carrier solutions in reservoirs 1-4.

5. Run G-code on Chemical Cooker hardware.

6. Cooker executes UCF-4 elemental blend per substance target.

Deck Position Convention

Default positions (override in Cooker platform config):

IP Boundary

Project 56 IP — the UCF-4 substrate, the substance→element mapping, the cessation research substrate. Retained by CGB.
Project 16 IP — the Chemical Cooker hardware and platform. Retained by CGB. Separate acquisition.
The bridge does not import Chemical Cooker code and does not copy proprietary logic. It emits JSON that conforms to the Cooker's published recipe schema. A Cooker owner uses their own Cooker platform to load and cook.

No Bundle

Purchasing Project 56 does NOT convey any right to Project 16 hardware or platform. Purchasing Project 16 does NOT convey any right to Project 56 substrate. Compatibility means the two products interoperate cleanly when both are separately acquired.

Cooker Compatibility Version

1.0 — first published compatibility (2026-07-03). Any future changes to the Cooker recipe schema will trigger a bump.

Files

cessation_ucf_to_recipe.py — bridge generator (Python)
recipes/ — generated .json and .gcode per substance + MANIFEST.json
COOKER_COMPATIBILITY.md — this file

Contact

Christopher Gabriel Brown

Email: crioneaka@outlook.com

Project 56 Store Integration

Target pages (add product card / listing entry to each):

1. https://cri-one.com/store/all-products.html — full catalog

2. https://cri-one.com/store/browse-by-sector/health-wellness.html — health/wellness sector browse

3. https://cri-one.com/store/research.html — research catalog

Dedicated product page (to be created): https://cri-one.com/store/56-cessation-database.html

(URL kept for continuity with existing store card links; product title inside the page reads "Cessation Alchemy Data").

Product identity

Name: Cessation Alchemy Data
Prior working title: Universal Non-Chemical Cessation Alchemy Database (retired)
Project #: 56
Category: Health / Wellness / Cessation Research
Status: Patent-pending
Bundle status: Standalone acquisition — NOT part of the All-In-One bundle
Classification: Non-opioid · Non-chemical primary
Tier ladder: Licensed Research $9,997 · Design Target $499,997 · Complete $50,000,000

Store copy guardrails applied

Says "patent-pending" not "patented"
"Design target" for all performance figures
"Computational research findings — not medical advice, not clinically tested, not FDA-approved"
Email + postal only; no phone; USA-only; USD only
IP retained by inventor across all tiers
No fabricated customer names or adoption claims

Imagery — Magento-compatible PNGs

Important: Magento does not render SVG. Upload the PNG variants. SVG source files are kept in ../figures/ for design/editing only.

Located in ../figures/:

Regenerator: figures/generate_pngs.py — rerun to rebuild any PNG at any time.

Palette (matches your existing store product style):

Teal #0E7A6E — vial cap, "C" badge, outlines
Coral #E37155 (with darker outline #B04A2C) — heart
Cream #F3E6C4 — vial body
Off-white #FBFAF6 — background

Motif: Simple flat-shape composition — vial holding six dots (the six UCFs) + "C" badge + heart. Matches the visual language of the Category E Bundle / Category B products already live on the store.

Push instructions

1. Deploy the PNG files to /store/media/project-56/:

   /store/media/project-56/cessation_symbol.png
   /store/media/project-56/cessation_symbol_256.png
   /store/media/project-56/cessation_symbol_200.png
   /store/media/project-56/cessation_icon.png
   /store/media/project-56/cessation_store_display.png
   /store/media/project-56/cessation_store_display_1000.png

(SVG source files are for editing only — do NOT upload to Magento.)

2. Create the product page at /store/56-cessation-database.html using ../cessation_store_description.html as the full content block. Use the deterministic prepare→push pipeline documented in the [[store-description-pipeline]] memory. Pre-process for ASCII-safety and escape characters to prevent double-escape / mojibake on the live page.

3. Insert the three card snippets into their respective destination pages:

all_products_card.html → /store/all-products.html
health_wellness_card.html → /store/browse-by-sector/health-wellness.html
research_card.html → /store/research.html

4. The card snippets already reference the SVGs at /store/media/project-56/ — deploy step 1 first so the images resolve.

Files in this directory

research_card.html — product card for /store/research.html (includes hero image)
health_wellness_card.html — product card for /store/browse-by-sector/health-wellness.html (includes hero image)
all_products_card.html — product card for /store/all-products.html (includes icon)
product_summary_block.html — reusable summary block (icon float-right)
STORE_INTEGRATION_NOTES.md — this file

Deep link back

Each store card links to the dedicated product page at /store/56-cessation-database.html (URL kept for continuity). The full product page content is at ../cessation_store_description.html — the aerophi-pattern exhaustive HTML including hero, stats strip, thesis quote, all six UCFs, all nine substance protocols, UWI test description, blood panel details, drug testing coverage, toxicology, precision dosing, pain management, resolution engine, chemistry comparison, history/predictions/counsel, Chemical Cooker compatibility note, companion projects list, commercial tiers with what-conveys / what-does-not, candidate acquirers, target market, contact block, and full disclaimer.

The deliverables also include:

../README.md — overview
../BUYER_PITCH.md — pharma acquisition pitch
../LICENSING.md — tier ladder + terms
../WEB_DESCRIPTION.html — condensed store-ready HTML (older format)
../HANDOFF_BLURB.md — short deliverable handoff
../MANIFEST.json — package manifest
../cessation_pharma_database.json — 134 KB database (v3.1.0)
../cessation_query.py — interactive query tool + resolution computation engine
../cooker_compat/ — Chemical Cooker (Project 16) recipe bridge

This archive contains 6 documents. The complete folder ships as the product.

Reviews

Write Your Own Review